2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow AlgiPharma AS: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Cross-over Study of OligoG in Subjects With Cystic Fibrosis. Fibrosis OligoG CF-5/20, Saline - Cystic Fibrosis | Phase 1 / Phase 2 | Completed | AlgiPharma AS | 26 | 2011-05-01 | 2015-01-14 |
| Safety and Efficacy of Inhaled OligoG CF-5/20 for the Treatment Cystic Fibrosis OligoG CF-5/20 - Cystic Fibrosis | Phase 1 | Completed | AlgiPharma AS | 26 | 2009-09-01 | 2016-03-23 |
Cystic Fibrosis (2) · Digestive System Diseases (1) · Genetic Diseases, Inborn (1) · Lung Diseases (1) · Pancreatic Diseases (1) · Respiratory Tract Diseases (1)
oligoG CF-5-20 (2) · Sodium Chloride (1)
United Kingdom (2) · Ireland (1)
Martin Walshaw, MD (1) · Salvatore Febbraro (1)